Clinical Trial Update: Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness [Phase 1]

View source ↗

Summary

Phase 1 clinical trial at Rutgers explored strategies to enhance motivation to quit smoking in individuals with schizophrenia or schizoaffective disorder; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 1 | Status: COMPLETED